|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/02 | |
| A61K 47/12 | |||
| A61K 9/00 | |||
| A61K 31/7088 | |||
| C12N 15/87 |
| (11) | Number of the document | 3153179 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16001381.9 |
| Date of filing the European patent application | 2006-05-19 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 102005023170 | 2005-05-19 | DE |
| (72) |
HOERR, Ingmar, DE
PASCOLO, Steve, CH
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | OPTIMIERTE INJEKTIONSFORMULIERUNG FÜR MRNA |
| OPTIMISED INJECTION FORMULATION FOR MRNA |